Core Investment Insights - Nvidia (NVDA.US) has established a significant position in CoreWeave (CRWV.US), acquiring approximately 24.18 million shares valued at around $896.7 million, representing 78.17% of its investment portfolio [1][2] - CoreWeave has seen a substantial increase of about 65% since its IPO earlier this year, making it the largest tech IPO supported by venture capital in the U.S. since 2021 [1][3] Portfolio Overview - As of the end of Q1, Nvidia's total portfolio value reached $1.15 billion, a significant increase from $305 million in the previous quarter, reflecting an inflow of approximately 78.17% [2][3] - Besides CoreWeave, Nvidia holds positions in five other companies, including Arm (ARM.US) with approximately 1.1 million shares valued at about $118 million, making up 10.25% of the portfolio [3][4] - Other notable holdings include Applied Digital (APLD.US) with around 7.72 million shares valued at approximately $43.4 million (3.78% of the portfolio), and Recursion Pharmaceuticals (RXRX.US) with about 7.71 million shares valued at around $40.8 million (3.55% of the portfolio) [3][4]

Group 1 - CoreWeave (CRWV.US) has seen a cumulative increase of approximately 65% since its IPO earlier this year, with Nvidia (NVDA.US) being a significant beneficiary of this rise [1] - As of the end of March, Nvidia held nearly $900 million worth of CoreWeave shares, which have appreciated to nearly $1.6 billion due to the recent surge in CoreWeave's stock price [1] - CoreWeave, which provides cloud-based rental services of Nvidia GPUs for AI model training, completed its IPO in late March, marking the largest tech IPO in the U.S. since 2021 [1] Group 2 - During the IPO roadshow, CoreWeave estimated an offering price range of $47 to $55 per share, but Nvidia intervened by purchasing $250 million worth of shares at $40 each to support the offering [2] - CoreWeave ultimately completed its IPO at $40 per share, raising $1.5 billion, with the CEO highlighting Nvidia as a "great partner" and describing their relationship as "symbiotic" [2] - As of Thursday, CoreWeave's stock closed at $65.77, with the company reporting a staggering 420% year-over-year revenue growth, significantly exceeding market expectations [2]